Patents by Inventor Rudolph J. Boisvenue

Rudolph J. Boisvenue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5618547
    Abstract: A series of 1,3-propanediones having a perfluoroalkyl group or a perfluorocycloalkyl group on one carbonyl, and a 3,5-disubstituted phenyl group on the other, are useful when administered to animals for the control of ectoparasites.
    Type: Grant
    Filed: March 10, 1994
    Date of Patent: April 8, 1997
    Assignee: British Technology Group Limited
    Inventors: Rudolph J. Boisvenue, Gary D. Crouse
  • Patent number: 4870109
    Abstract: A series of 1,3-propanediones having a perfluoroalkyl group or a perfluorocycloalkyl group on one carbonyl, and a 3,5-disubstituted phenyl group on the other, are useful when administered to animals for the control of ectoparasites.
    Type: Grant
    Filed: November 20, 1987
    Date of Patent: September 26, 1989
    Assignee: Eli Lilly and Company
    Inventors: Rudolph J. Boisvenue, Gary D. Crouse
  • Patent number: 4692468
    Abstract: This invention is directed to the use of a class of N-(2,2-difluoroalkanoyl)-o-phenylenediamines as an agent for the control of certain colonial insects, i.e., ants and termites.
    Type: Grant
    Filed: September 9, 1982
    Date of Patent: September 8, 1987
    Assignee: Eli Lilly and Company
    Inventor: Rudolph J. Boisvenue
  • Patent number: 4421759
    Abstract: This invention is directed to the use of certain benzimidazoles and benzimidazolines as an agent for the control of colonial insects, especially fire ants.
    Type: Grant
    Filed: July 27, 1981
    Date of Patent: December 20, 1983
    Assignee: Eli Lilly and Company
    Inventor: Rudolph J. Boisvenue
  • Patent number: 4331652
    Abstract: Controlled release formulations useful in controlling endoparasitic infestation in animals over a prolonged period of time are comprised of an anthelmintic agent intimately dispersed throughout a copolymeric matrix derived from the condensation of about 60 to about 95 weight percent of lactic acid and about 40 to about 5 weight percent of glycolic acid, said copolymeric matrix being substantially free of polymerization catalyst.
    Type: Grant
    Filed: December 24, 1980
    Date of Patent: May 25, 1982
    Assignee: Eli Lilly and Company
    Inventors: Nelson H. Ludwig, Rudolph J. Boisvenue